共 50 条
Barriers and strategies to achieve a cure for HIV
被引:98
|作者:
Pitman, Matthew C.
[1
,2
]
Lau, Jillian S. Y.
[3
]
McMahon, James H.
[3
,4
]
Lewin, Sharon R.
[1
,2
,3
]
机构:
[1] Univ Melbourne, Peter Doherty Inst Infect & Immun, Melbourne, Vic 3000, Australia
[2] Royal Melbourne Hosp, Melbourne, Vic, Australia
[3] Monash Univ, Alfred Hosp, Dept Infect Dis, Melbourne, Vic, Australia
[4] Monash Med Ctr, Dept Infect Dis, Clayton, Vic, Australia
来源:
LANCET HIV
|
2018年
/
5卷
/
06期
基金:
英国医学研究理事会;
澳大利亚国家健康与医学研究理事会;
美国国家卫生研究院;
关键词:
CD4(+) T-CELLS;
SUPPRESSIVE ANTIRETROVIRAL THERAPY;
BROADLY NEUTRALIZING ANTIBODIES;
TREATMENT INTERRUPTION;
IN-VIVO;
BISPECIFIC ANTIBODIES;
POSTTREATMENT CONTROL;
HIV-1-INFECTED CELLS;
INFECTED INDIVIDUALS;
VIRAL RESERVOIR;
D O I:
10.1016/S2352-3018(18)30039-0
中图分类号:
R392 [医学免疫学];
Q939.91 [免疫学];
学科分类号:
100102 ;
摘要:
9 years since the report of a cure for HIV after C-C chemokine receptor type 5.32 stem cell transplantation, no other case of HIV cure has been reported, despite much research. However, substantial progress has been made in understanding the biology of the latent HIV reservoir, and in measuring the amount of virus that persists after antiretroviral therapy (ART) with increasingly sophisticated approaches. This knowledge is being translated into a long pipeline of clinical trials seeking to reduce viral persistence in participants on suppressive treatment and ultimately to allow safe cessation of ART. In this Review, we discuss the main barriers preventing the development of an HIV cure, methods used to measure HIV persistence in individuals on ART, clinical strategies that aim to cure HIV, and future directions for studies in the field of HIV cure research.
引用
收藏
页码:E317 / E328
页数:12
相关论文